This podcast series from the Academy's Committee on Aging features leading experts who discuss clinical experiences and the differences in caring for older adults.

In today's podcast, Dr. Susan Bressler discusses the Home Monitoring of the Eye (HOME) study, which evaluated the success of home monitoring of patients with age-related macular degeneration (AMD). In the study, patients at high risk of developing choroidal neovascularization (CNV) were given the ForeseeHome device (Notal Vision) to use at home and monitor their visual field changes. The device tracks a central distortion map, comparing changes against a normal database as well as an individual's baseline. Results are transmitted to a central monitoring center, allowing patients and their doctors to be aware of significant changes as they occur and to initiate treatment much earlier in the disease process. Because early intervention with anti-VEGF therapy is critical to maintaining visual acuity in these patients, Dr. Bressler believes those with intermediate AMD (bilateral large drusen) or advanced AMD in one eye are likely to benefit from the use of a home monitoring device.

  Funded in part by the Retina Research Foundation